This web site was copied prior to January 20, 2005. It is now a Federal record managed by the National Archives and Records Administration. External links, forms, and search boxes may not function within this collection. Learn more.   [hide]
 
Cancer.gov0 0 Division of Cancer Prevention

 

DCP Home
Dictionary
Site Map
Search

PROSTATE, LUNG, COLORECTAL & OVARIAN CANCER SCREENING TRIAL (PLCO)

About the Trial

The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, or PLCO, is a large-scale clinical trial to determine whether certain cancer screening tests reduce deaths from prostate, lung, Colorectal and Ovarian cancer. In addition, there are numerous epidemiologic and ancillary studies going on that will answer other crucial questions about these cancers and these screening tests.


Why are only these four cancer sites being studied?
Prostate, lung, Colorectal and Ovarian cancers account for more than 48 percent of all cancers diagnosed and 49 percent of all cancer deaths in the United States. About 255,600 people will die from these cancers this year.


Who supports the PLCO?
The PLCO is sponsored and run by the National Cancer Institute, one of the National Institutes of Health and part of the U.S. Public Health Service.


Where is the PLCO Trial taking place?
The trial is taking place at 10 screening centers around the United States. For a full list, go to the Screening Centers page.

Sections

Updates

Facts about PLCO Cancers

Screening Centers

Participant Newsletters

Dietary Questionnaires

Resource Links

PLCO Intranet for Staff Only

Home Page

HOME | DICTIONARY | SITE MAP | SEARCH
ACCESSIBILITY | PRIVACY POLICY | CONTACT DCP

National Cancer Institute Department of Health and Human Services National Institutes of Health FirstGov.gov